Skip to main content

Table 3 Vaccine effectiveness against AGE hospitalization during the post-vaccine period by age group

From: Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001–2016

Age Group Direct VE, %
(95% CI)
Indirect VE, %
(95% CI)
Overall VE, %
(95% CI)
Total VE, %
(95% CI)
< 1 59* (54, 64) 25* (12, 36) 49* (37, 58) 69* (63, 74)
1 63* (55, 69) 38* (20, 52) 59* (46, 68) 77* (71, 81)
2 57* (44, 66) 28* (5, 46) 49* (33, 62) 69* (59, 76)
3 60* (49, 68) 16 (− 7, 34) 42* (27, 55) 67* (58, 74)
4 54* (42, 64) 11 (− 13, 29) 33* (16, 46) 60* (47, 70)
0–4 56* (50, 61) 27* (15, 38) 48* (40, 55) 68* (63, 72)
5–9 33* (19, 45) 16* (8, 24) 20* (12, 27) 44* (31, 55)
  1. *Represents significance at the alpha = 0.05 level